Bradley Foster & Sargent Inc Novartis Ag Transaction History
Bradley Foster & Sargent Inc
- $5.77 Billion
- Q4 2024
A detailed history of Bradley Foster & Sargent Inc transactions in Novartis Ag stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 28,758 shares of NVS stock, worth $3.1 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
28,758
Previous 28,883
0.43%
Holding current value
$3.1 Million
Previous $3.32 Million
15.77%
% of portfolio
0.05%
Previous 0.06%
Shares
28 transactions
Others Institutions Holding NVS
# of Institutions
1,448Shares Held
130MCall Options Held
999KPut Options Held
1.32M-
Dodge & Cox San Francisco, CA12.2MShares$1.32 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.19 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$881 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.98MShares$752 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.58MShares$601 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...